Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX) 66.7% HIGHER; today announced that the European Patent Office granted to Brookhaven Science Associates/Brookhaven ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE